Matches in SemOpenAlex for { <https://semopenalex.org/work/W78454140> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W78454140 endingPage "407" @default.
- W78454140 startingPage "2387" @default.
- W78454140 abstract "Results of a previous study show abnormal plasma lipids in progressive rod-cone degeneration (prcd)-affected dogs, with lower docosahexaenoic acid (DHA; 22:6n-3) and cholesterol levels but no differences in other plasma fatty acids, lipids, triglycerides, and fat-soluble vitamins. There is also an increase of the DHA precursor 22:5n-3, so that the ratio of 22:5n-3 to 22:6n-3 is higher in affected than in normal dogs. Because DHA is the predominant esterified fatty acid in rod outer segment (ROS) phospholipids, these findings suggest a possible causal association between abnormal plasma lipid levels and retinal degeneration. In the current study, dietary supplements rich in 22:6n-3 were used to determine whether plasma, liver, and rod outer segment phospholipid composition can be altered to modify the prcd disease phenotype.prcd-affected and normal control dogs were given DHA-enriched supplements for short (7- and 25-day) and long (21-week) periods, and the fatty acid composition of plasma, liver, and rod outer segment phospholipids were examined. In the long-term study, electroretinography and morphology were used to assess modification of the retinal degeneration phenotype.Administration of DHA-enriched supplements resulted in increases in plasma DHA and n-3 polyunsaturated fatty acids and in decreases in some n-6 fatty acids in normal and prcd-affected dogs. Similar increases in DHA and n-3 fatty acids were observed in the liver, but affected dogs had significantly higher levels at all supplementation time points examined. In contrast, the ROS of affected dogs had statistically lower (approximately 20%) DHA levels, and these levels could not be increased with dietary supplementation. The disease phenotype could not be modified by DHA-enriched supplements.Regardless of the sustained three- to fourfold elevation in plasma and liver DHA that occurs as the result of supplementation, the ROS DHA levels remain unchanged, and the prcd disease phenotype is not modified by the dietary manipulation. These findings could be the result of a reduction in the synthesis of DHA-containing phospholipids in the retinas of affected dogs; or, alternatively, there could be a reduction in DHA uptake, transport, or storage within the retinal pigment epithelium-photoreceptor complex." @default.
- W78454140 created "2016-06-24" @default.
- W78454140 creator A5004338167 @default.
- W78454140 creator A5016715548 @default.
- W78454140 creator A5067298691 @default.
- W78454140 creator A5078087543 @default.
- W78454140 date "1997-10-01" @default.
- W78454140 modified "2023-10-16" @default.
- W78454140 title "Diets enriched in docosahexaenoic acid fail to correct progressive rod-cone degeneration (prcd) phenotype." @default.
- W78454140 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9344362" @default.
- W78454140 hasPublicationYear "1997" @default.
- W78454140 type Work @default.
- W78454140 sameAs 78454140 @default.
- W78454140 citedByCount "26" @default.
- W78454140 countsByYear W784541402012 @default.
- W78454140 countsByYear W784541402013 @default.
- W78454140 countsByYear W784541402016 @default.
- W78454140 countsByYear W784541402017 @default.
- W78454140 countsByYear W784541402021 @default.
- W78454140 crossrefType "journal-article" @default.
- W78454140 hasAuthorship W78454140A5004338167 @default.
- W78454140 hasAuthorship W78454140A5016715548 @default.
- W78454140 hasAuthorship W78454140A5067298691 @default.
- W78454140 hasAuthorship W78454140A5078087543 @default.
- W78454140 hasConcept C126322002 @default.
- W78454140 hasConcept C134018914 @default.
- W78454140 hasConcept C19038510 @default.
- W78454140 hasConcept C2777171753 @default.
- W78454140 hasConcept C2778163477 @default.
- W78454140 hasConcept C2778918659 @default.
- W78454140 hasConcept C41625074 @default.
- W78454140 hasConcept C543025807 @default.
- W78454140 hasConcept C55493867 @default.
- W78454140 hasConcept C71924100 @default.
- W78454140 hasConcept C86803240 @default.
- W78454140 hasConceptScore W78454140C126322002 @default.
- W78454140 hasConceptScore W78454140C134018914 @default.
- W78454140 hasConceptScore W78454140C19038510 @default.
- W78454140 hasConceptScore W78454140C2777171753 @default.
- W78454140 hasConceptScore W78454140C2778163477 @default.
- W78454140 hasConceptScore W78454140C2778918659 @default.
- W78454140 hasConceptScore W78454140C41625074 @default.
- W78454140 hasConceptScore W78454140C543025807 @default.
- W78454140 hasConceptScore W78454140C55493867 @default.
- W78454140 hasConceptScore W78454140C71924100 @default.
- W78454140 hasConceptScore W78454140C86803240 @default.
- W78454140 hasIssue "11" @default.
- W78454140 hasLocation W784541401 @default.
- W78454140 hasOpenAccess W78454140 @default.
- W78454140 hasPrimaryLocation W784541401 @default.
- W78454140 hasRelatedWork W1907696832 @default.
- W78454140 hasRelatedWork W1966073223 @default.
- W78454140 hasRelatedWork W1966657398 @default.
- W78454140 hasRelatedWork W1983808198 @default.
- W78454140 hasRelatedWork W2088321413 @default.
- W78454140 hasRelatedWork W2092346493 @default.
- W78454140 hasRelatedWork W2098708274 @default.
- W78454140 hasRelatedWork W2134856213 @default.
- W78454140 hasRelatedWork W295681449 @default.
- W78454140 hasRelatedWork W381575141 @default.
- W78454140 hasVolume "38" @default.
- W78454140 isParatext "false" @default.
- W78454140 isRetracted "false" @default.
- W78454140 magId "78454140" @default.
- W78454140 workType "article" @default.